Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Clinical Outcomes and Prognostic Implications of Tavr in Patients With Active Cancer: A Meta-Analysis Publisher Pubmed



Saberian P1 ; Contreras R2 ; Gurram A3 ; Nasrollahizadeh A4 ; Keetha NR5 ; Nguyen AL6 ; Nayak SS2 ; Keivanlou MH7 ; Hashemi M1 ; Aminisalehi E7 ; Ameen D2
Authors

Source: Clinical Cardiology Published:2025


Abstract

Background: Transcatheter aortic valve replacement (TAVR) is an alternative to surgical aortic valve replacement (SAVR) for high-risk patients with severe aortic stenosis (AS). However, the clinical outcomes and prognostic implications of TAVR in patients with active cancer remain uncertain. This meta-analysis evaluates procedural success, complications, and survival outcomes of TAVR in patients with and without active cancer. Methods: A comprehensive literature search was conducted across PubMed, Scopus, and Web of Science databases. Statistical analysis was performed using a random-effects model. Statistical analyses were conducted using STATA version 18.0. Results: The results of the meta-analysis showed no significant difference in in-hospital mortality between cancer and non-cancer patients (OR = 1.17; 95% CI: 0.83, 1.65; p = 0.27). Similarly, 30-day mortality did not differ between the two groups (OR = 0.93; 95% CI: 0.72, 1.19; p = 0.49). However, 1-year mortality was significantly higher in cancer patients (OR = 1.93; 95% CI: 1.45, 2.56; p < 0.01). Two-year mortality was also higher in cancer patients (OR = 2.65; 95% CI: 1.79, 3.93; p < 0.01). No significant differences were observed in major bleeding, acute kidney injury, stroke, or permanent pacemaker implantation between the groups. Conclusion: While TAVR offers comparable in-hospital and short-term survival outcomes for cancer and non-cancer patients, long-term mortality is significantly higher in those with active cancer. These findings suggest that TAVR is a viable option for cancer patients with severe AS but requires careful long-term prognostic considerations. Further studies are needed to optimize management strategies for this complex population. © 2025 The Author(s). Clinical Cardiology published by Wiley Periodicals LLC.
Related Docs
View other Related Docs
1. Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: Updated Meta-Analysis, American Journal of Cardiology (2025)
2. Trends in Transcatheter Versus Surgical Aortic Valve Replacement Outcomes in Patients With Low-Surgical Risk: A Systematic Review and Meta-Analysis of Randomized Trials, Journal of the American Heart Association (2024)
3. Clinical Outcomes and the Impact of Valve Morphology for Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valves: A Systematic Review and Meta-Analysis, Catheterization and Cardiovascular Interventions (2023)
Experts (# of related papers)
View all Related Experts
Kaveh Hosseini (3)
Tahereh Davarpasand (2)
Other Related Docs
4. Clinical Outcomes of Transcatheter Aortic Valve Replacement in Patients With Radiation-Induced Aortic Stenosis: A Systematic Review and Meta-Analysis, Frontiers in Cardiovascular Medicine (2025)
5. Effect of Bmi on Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis, Progress in Cardiovascular Diseases (2023)
6. Concomitant Coronary Artery Bypass Graft and Aortic and Mitral Valve Replacement for Rheumatic Heart Disease: Short- and Mid-Term Outcomes, Interactive Cardiovascular and Thoracic Surgery (2015)
7. Outcomes of Transcatheter Aortic Valve Replacement Using Third-Generation Balloon-Expandable Versus Self-Expanding Valves: A Meta-Analysis, Journal of the Society for Cardiovascular Angiography and Interventions (2024)
8. Statins and Mortality of Patients After Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis, Angiology (2023)
9. Triple Valve Replacement for Rheumatic Heart Disease: Short- and Mid-Term Survival in Modern Era, Interactive Cardiovascular and Thoracic Surgery (2015)
10. Stroke Risk After Mitral Valve Interventions: A Systematic Review and Network Meta-Analysis, American Journal of Cardiology (2024)
11. Predictive Potential of Pre-Procedural Cardiac and Inflammatory Biomarkers Regarding Mortality Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis, Heart and Lung (2025)
12. Follow-Up Report of Patients With Moderate Aortic Valve Regurgitation After Cardiac Surgery, Texas Heart Institute Journal (2024)
13. Short-Term, Mid-Term, and Long-Term Outcomes of Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expanding Valves: A Meta-Analysis of Randomized Controlled Trials, Clinical Cardiology (2025)
14. Sex-Related Differences in Survival and Safety Outcomes After Transcatheter Aortic Valve Replacement: A Meta-Analysis of Reconstructed Time-To-Event Data, European Heart Journal - Quality of Care and Clinical Outcomes (2025)
15. National Surveillance of Cancer Survival in Iran (Irancansurv): Analysis of Data of 15 Cancer Sites From Nine Population-Based Cancer Registries, International Journal of Cancer (2022)
16. Cardiovascular Events Among Men With Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors: A Systematic Review, Meta-Analysis, and Network Meta-Analysis, Prostate Cancer and Prostatic Diseases (2025)
17. Long-Term Survival and Prognostic Factors of Breast Cancer, Archives of Iranian Medicine (2022)
18. Evaluation of Optimal Number of Neoadjuvant Chemotherapy Cycles and Cytoreductive Surgery in Women With Ovarian Cancer, Indian Journal of Gynecologic Oncology (2024)
19. Efficacy of Echocardiographic Parameters in Predicting Chemoradiotherapy-Induced Cardiotoxicity in Patients With Breast Cancer, Iranian Heart Journal (2023)
20. Estimating the Treatment Effect in Patients With Gastric Cancer in the Presence of Noncompliance, Gastroenterology and Hepatology from Bed to Bench (2021)